Duck hepatitis B photoinactivation by dimethylmethylene blue in RBC suspensions

Transfusion

Volumn 41, Issue 9, 2001, Pages 1154-1158

  Wagner, Stephen J ^a,b,c   Skripchenko, Andrey ^a,b   Pugh, John C ^a,b   Suchmann, Donna B ^a,b   Khalid Ijaz, M ^a,b  

^a HOLLAND LABORATORY   (United States)

^b MICROBIOTEST Inc   (United States)

^c AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE;

ANTIVIRAL ACTIVITY; ARTICLE; BLOOD SAMPLING; ERYTHROCYTE TRANSFUSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; INFECTION RISK; PHOTOACTIVATION; PHOTOTHERAPY; SEROCONVERSION; SUSPENSION; VIRUS CULTURE; VIRUS INACTIVATION; VIRUS PARTICLE;

DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ERYTHROCYTES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS B VIRUS, DUCK; HUMANS; LIGHT; METHYLENE BLUE; VIRUS ACTIVATION;

EID: 0034847934     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41091154.x     Document Type: Article

References (33)

1. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C
2. The risk of transfusion-transmitted infection
3. Risk of hepatitis and retroviral infections among blood donors and introduction of nucleic acid testing (NAT)
4. Reducing the infectivity of blood components - What we have learned
5. Strategies for viral inactivation
6. Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and RBC concentrates
7. Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virus
8. Methodological approaches to disinfection of human hepatitis B virus
9. Use of surrogate models for testing efficacy of disinfectants against hepatitis B virus
10. Hepatitis B virus efficacy testing: Qualificaton of an avian Hepadavirus in vitro system that uses primary duck hepatocyte cultures
11. The molecular biology of the hepatitis B viruses
12. Duck hepatitis B virus: A model to assess efficacy of disinfectants against hepadnavirus infectivity
13. Validation of virus inactivation by heat treatment in the manufacture of diaspirin crosslinked hemoglobin
14. Chemical disinfection of duck hepatitis B virus: A model for inactivation of infectivity of hepatitis B virus
15. Photochemical inactivation of duck hepatitis B virus in human platelet concentrates: A model of surrogate human hepatitis B virus infectivity
16. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light
17. Duck hepatitis B virus inactivation and 8-methyoxypsoralen photoadduct formation in human platelet concentrates
18. Establishment of an in-use testing method for evaluating disinfection of surgical instruments using the duck hepatitis B model
19. Chromatographic removal and heat inactivation of hepatitis B virus during the manufacture of human albumin
20. Evaluation of disinfection and sterilization of reusable angioscopes with the duck hepatitis B model
21. Inactivation of duck hepatitis B virus by a hydrogen peroxide gas plasma sterilization system: Laboratory and 'in use' testing
22. Quantification of infectious duck hepatitis B virus by radioimmunofocus assay
23. Preservation of RBC properties after virucidal phototreatment with dimethylmethylene blue
24. High-yield preparation of isolated rat liver parenchymal cells
25. Preparation of isolated rat liver cells
26. Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind virus particles
27. A simple method of estimating fifty percent end points
28. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus
29. Inactivation of WBCs in RBC suspensions by photoactive phenothiazine dyes: Comparison of dimethylmethylene blue and MB
30. Photonuclease activity of Taylor's blue
31. Identification of the target responsible for M13 virus inactivation by dimethylmethylene blue and light treatment
32. Factors affecting virus photoinactivation by a series of phenothiazine dyes
33. The photoinactivation of an RNA animal virus, vesicular stomatitis virus, with the aid of newly synthesized psoralen derivatives